BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2002
View Archived Issues
Drug pipeline for cystic fibrosis
Read More
Biovitrum presents novel 5-HT6 antagonists for obesity, diabetes and CNS disorders
Read More
Novel PPARalpha/gamma receptor agonists in early development at Roche
Read More
Guilford researchers prepare and test new series of NAALADase inhibitors
Read More
Prinomastat monotherapy in low-risk myelodysplastic syndrome
Read More
New data on the HDAC inhibitor MS-275 in leukemia
Read More
Efficacy and safety of tipifarnib in leukemia and other hematological disorders
Read More
Clinical results reported for lonafarnib in hematological malignancies
Read More
Epothilone B effective and well tolerated in advanced breast cancer
Read More
Axovan enters research collaboration with Biolipox to discover antiinflammatory drugs
Read More
Cephalon reacquires modafinil rights in key E.U. countries
Read More
Xcytrin enters pivotal trial for treatment of brain metastases in NSCLC patients
Read More
NeoPharm seeks FDA guidance on IL-13-PE38 trial design and registration plan
Read More
Pfizer and Eyetech form collaboration to develop and commercialize Macugen
Read More
License agreement for Befar in South Korea
Read More
Phase I trial of BI-K0376 completes enrollment
Read More
TBC-MVA smallpox vaccine enters phase I testing
Read More
Neurocrine Biosciences and Pfizer enter global agreement for indiplon
Read More
STTR grant supports antibody research at Acorda and Mayo Clinic for treatment of MS
Read More
Progenics commences phase III program for methylnaltrexone
Read More
Novartis files NDA for Certican for prevention of kidney and heart transplant rejection
Read More
Positive opinion in E.U. for Lilly's teriparatide in established osteoporosis
Read More
Restrictions on the use of new lung cancer drug
Read More
Monoclonal antibodies targeting CD40 claimed by Kirin Brewery
Read More
GSK identifies new series of human PPAR agonists and potential uses
Read More
New CRF receptor ligands designed by BMS
Read More